Spinal cord stimulation device manufacturer Saluda Medical won the support of Boston Scientific for a round that took its total funding past $125m.

Australia-based spinal cord stimulation device provider Saluda Medical attracted $75m in equity funding on Friday from medical device manufacturer Boston Scientific, healthcare-focused investment group Redmile and an undisclosed institutional investor. Founded in 2013, Saluda Medical develops medical devices driven by neuromodulation techniques which stimulate the human nervous system for therapeutic or diagnostic purposes. The company‚Äôs…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.